Salkind Gene 4/A
4/A · Mobiquity Technologies, Inc. · Filed Aug 22, 2024
Insider Transaction Report
Form 4/AAmended
Salkind Gene
Director10% Owner
Transactions
- Conversion
Common Stock
2024-08-06$0.20/sh+7,675,160$1,535,032→ 8,223,695 total - Conversion
Series H Preferred Stock
2024-08-06−751,973→ 581,544 totalExercise: $0.20From: 2023-12-15→ Common Stock (7,519,730 underlying)
Footnotes (4)
- [F1]Not applicable.
- [F2]The securities listed in Table I and II are securities owned directly by Dr. Salkind and his wife and by a family trust.
- [F3]Includes dividend shares issued upon conversion.
- [F4]Includes (i) 420,000 common shares underlying convertible notes, (ii) 59,211 shares underlying warrants exercisable at $60 per share, (iii) 2,333 shares underlying options exercisable at $68.48 per share and (iv) 100,000 shares underlying options exercisable at $.20 per share.